Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
  Phillip Investor Notes

22-04-2020(Wed) 21-04-2020(Tue) 20-04-2020(Mon) 17-04-2020(Fri) 16-04-2020(Thu)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
13 Sep, 2019 (Friday)

For 1H2019, revenue increased 11.7% to RMB2,964.4 million YoY, which would be RMB3,401.5 million increasing 14.4% YoY if excluding the effect of ¡§two-invoice system¡¨; gross profit increased 17.7% to RMB2,217.5 million YoY, which would be RMB2,023.2 million increasing 16% YoY if excluding the effect of ¡§two-invoice system¡¨. Profit for the period increased 22.2% to RMB1,167.5 million. The Board declared an interim dividend of RMB0.1883 per share, increasing 22.6% YoY. The CAGRs for revenue and profit for the period of last 10 years are 26.3% and 30.8% respectively. In June 2019, the company through its subsidiary signed a license agreement with a subsidiary of Sun Pharma, and gained an exclusive license with the right to grant sublicenses under Sun Pharma`s intellectual property rights and regulatory documentation to develop and commercialize its product Cyclosporine A, 0.09% Eye Drops in Greater China. Cyclosporine A, 0.09% Eye Drops has the potential to fulfill the current unmet clinical needs of the patients with dry eye, providing them with a new satisfactory treatment option.
Buy-in Price: $8.50, Target Price: $10.30, Cut Loss Price: $8.00

Tokio Marine Holdings, Inc. (8766)
Founded in 1879 as Japan's first insurance company. Established as an insurance holding company in 2001 via a merger between Tokio Marine & Fire Insurance and Nichido Fire and Marine Insurance. Carries out domestic non-life insurance business, domestic life insurance business, overseas insurance business, and finance / general businesses. Has subsidiaries such as Tokio Marine & Nichido Fire Insurance and Insurance, etc.For 1Q (Apr-Jun) results of FY2020/3 results announced on 9/8, ordinary revenue decreased by 0.2% to 1.394119 trillion yen compared to the same period the previous year, ordinary income increased by 8.7% to 150.058 billion yen, and net income increased by 10.8% to 112.714 billion yen. Overseas businesses mainly in North America, South America and Asia have continued to perform strongly. Also has profit increase in domestic businesses when excluding the increase in the rate of transfer for the reserve for casualty, etc.For its full year plan, ordinary profit is expected to increase by 9.3% to 455 billion yen compared to the previous year, and net income to increase by 18.4% to 325 billion yen. For the 1Q progress rate, net income is at 34.7%. Formed a business partnership on 26/7 with the Israeli Harel Insurance Investments and Financial Services Ltd. Intends to pick out promising Israeli venture companies and technologies.

China Resources Beer (291.HK) - Acquisition of Heineken helping to open up mid-to high-end market¡FLooking forward to harvest period

Investment Summary

China Resources Beer's interim revenue of FY 2019 increased by 7.2% y.o.y. to RMB18.825 billion , and net profit increased by 24.1% to RMB 1.871 billion. Although the gross profit margin facing the pressure of rising raw material costs, thanked to the optimization of product mix, it improved by 1.9ppt. y.o.y. to 37.8%.

The increase in revenue during the period was mainly due to the 7% increase in sales volume of the mid- to high-end beer, which drove the overall beer sales volume and average price to increase by 2.6% and 4.5% respectively. This was benefited from the brand repositioning strategy, further upgrade of product mix and contribution from the acquisition of Heineken China. CRB's overall beer sales growth performance was better than the industry level, and better than the management's original annual sales target which was to be flat y.o.y.

CRB's acquisition of Heineken China was completed by the end of April. The contribution from such operation does not bring significant impact to the company's financial performance for 1H of FY2019. This long-term strategic partnership will provide an important strategic opportunity for our development in China's premium beer market.

According to the management team, the integration with Heineken China is going smoothly. The integration includes work teams, channels and markets. The existing channel networks in 26 provinces have launched Heineken beer products. It plans to accelerate the integration process. It is expected to complete the integration within this year and further improvement and optimization will be carried out next year.

We expect that with the acquisition, the share of mid- to high- end business i.e. selling price more than RMB5, will further increase, with the possibility of increasing to over 50% between 2020 and 2021. The company's mid-to-high-end products accounted for 39% of the total revenue in FY2017, and increase to 43% in 2018. Heineken China recorded a total after-tax loss of RMB66.8 million in 2017. This was mainly due to the increase in marketing expenses as lacks the channels to digest or effectively reach the end market. With the cooperation of CRB, we believe this can be improved.

The percentage share of selling and distribution expense to revenue increased by 0.8 ppt to 15.4%, which was due to the impact of higher investment in advertisement and the acquisition of Heineken China. The company continued to pursue capacity optimization and organizational restructuring, resulting in staff compensation and resettlement expenses.The percentage share of general and administrative expenses was decreased by 1.3 ppt. To 10.3%.During the period, 1 brewery ceased operation. In the meantime, 3 breweries were added after the acquisition of Heineken China.

As of the end of June 2019, the company operated 80 breweries across 25 provinces, municipalities and autonomous regions in Mainland China, with an aggregate annual production capacity of approximately 21,600,000 kiloliters. We expect EPS of FY2020 will be RMB0.65, with target price HKD42.7, and target price-earnings ratio 60 times . (current price as of September 11, 2019)

Investment Thesis & Valuation

We expect EPS of FY2020 will be RMB0.65, with target price HKD42.7,and target price-earnings ratio 60 times . Potential investment risks include revenue growth or channel expansion missing expectation, market competition deteriorates¡Ahuge fluctuations of raw material costs . (current price as of 11 September, 2019)


Click Here for PDF format...

Recommendation on 13-9-2019
Price on Recommendation Date$ 42.400
Suggested purchase priceN/A
Target Price$ 42.700
Writer Info
Tracy Ku
(Research Analyst)
Tel: +852 2277 6516

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%

A-H spread
Stock Code H share
A share
H share

Oversea Research Reports

Investment Service Centre

Enquiry : 2277 6666 OR
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2019 Phillip Securities (HK) Ltd. All Rights Reserved.

Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]